Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura

Fabrizio Fabris, Raffaella Scandellari, Elisabetta Ruzzon, Maria Luigia Randi, Guido Luzzatto, Antonio Girolami

Blood (2004) 103 (12): 4562–4564.

https://doi.org/10.1182/blood-2003-09-3352

Published: 2004

Journal Articles

The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study

Bruno Girolami, Paolo Prandoni, Piero M. Stefani, Cinzia Tanduo, Paola Sabbion, Petra Eichler, Roberto Ramon, Giovannella Baggio, Fabrizio Fabris, Antonio Girolami

Blood (2003) 101 (8): 2955–2959.

https://doi.org/10.1182/blood-2002-07-2201

Published: 2003

Journal Articles

An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant

Alessandra Casonato, Francesca Sartorello, Maria Grazia Cattini, Elena Pontara, Carmen Soldera, Antonella Bertomoro, Antonio Girolami

Blood (2003) 101 (1): 151–156.

https://doi.org/10.1182/blood-2002-04-1046

Published: 2003

Journal Articles

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis

Paolo Prandoni, Anthonie W. A. Lensing, Andrea Piccioli, Enrico Bernardi, Paolo Simioni, Bruno Girolami, Antonio Marchiori, Paola Sabbion, Martin H. Prins, Franco Noventa, Antonio Girolami

Blood (2002) 100 (10): 3484–3488.

https://doi.org/10.1182/blood-2002-01-0108

Published: 2002

Journal Articles

The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study

Daniela Tormene, Paolo Simioni, Paolo Prandoni, Francesca Franz, Patrizia Zerbinati, Giulio Tognin, Antonio Girolami

Blood (2002) 100 (7): 2403–2405.

https://doi.org/10.1182/blood-2002-04-1186

Published: 2002

Journal Articles

Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations

Michael Kalafatis, Paolo Simioni, Daniela Tormene, Daniel O. Beck, Sonia Luni, Antonio Girolami

Blood (2002) 99 (11): 3985–3992.

https://doi.org/10.1182/blood.V99.11.3985

Published: 2002

Journal Articles

Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study

Paolo Simioni, Daniela Tormene, Paolo Prandoni, Patrizia Zerbinati, Sabrina Gavasso, Philip Cefalo, Antonio Girolami

Blood (2002) 99 (6): 1938–1942.

https://doi.org/10.1182/blood.V99.6.1938

Published: 2002

Journal Articles

Reduced von Willebrand factor survival in type Vicenza von Willebrand disease

Alessandra Casonato, Elena Pontara, Francesca Sartorello, Maria Grazia Cattini, Maria Teresa Sartori, Roberto Padrini, Antonio Girolami

Blood (2002) 99 (1): 180–184.

https://doi.org/10.1182/blood.V99.1.180

Published: 2002

Journal Articles

Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis

Paolo Simioni, Paolo Prandoni, Anthonie W. A. Lensing, Davide Manfrin, Daniela Tormene, Sabrina Gavasso, Bruno Girolami, Corrado Sardella, Martin Prins, Antonio Girolami

Blood (2000) 96 (10): 3329–3333.

https://doi.org/10.1182/blood.V96.10.3329

Published: 2000

Journal Articles

Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family

Elisabetta Castoldi, Paolo Simioni, Michael Kalafatis, Barbara Lunghi, Daniela Tormene, Domenico Girelli, Antonio Girolami, Francesco Bernardi

Blood (2000) 96 (4): 1443–1448.

https://doi.org/10.1182/blood.V96.4.1443

Published: 2000

Journal Articles

The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort Study

Bernd-Jan Sanson, Paolo Simioni, Daniela Tormene, Marco Moia, Philip W. Friederich, Menno V. Huisman, Paolo Prandoni, Alessandra Bura, László Rejtő, Philip Wells, Pier M. Mannucci, Antonio Girolami, Harry R. Büller, Martin H. Prins

Blood (1999) 94 (11): 3702–3706.

https://doi.org/10.1182/blood.V94.11.3702

Published: 1999

Journal Articles

Platelet-Derived Factor Va/Va Leiden Cofactor Activities Are Sustained on the Surface of Activated Platelets Despite the Presence of Activated Protein C

Rodney M. Camire, Michael Kalafatis, Paolo Simioni, Antonio Girolami, Paula B. Tracy

Blood (1998) 91 (8): 2818–2829.

https://doi.org/10.1182/blood.V91.8.2818.2818_2818_2829

Published: 1998

Journal Articles

The Effect of Ellagic Acid on Coagulation in Vivo

ANTONIO GIROLAMI, M.D., DOMENICO AGOSTINO, V.M.D., EUGENE E. CLIFFTON, M.D.

Blood (1966) 27 (1): 93–102.

https://doi.org/10.1182/blood.V27.1.93.93

Published: 1966

NARROW

Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura

The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study

An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis

The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study

Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations

Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study

Reduced von Willebrand factor survival in type Vicenza von Willebrand disease

Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis

Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family

The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort Study

Platelet-Derived Factor Va/Va Leiden Cofactor Activities Are Sustained on the Surface of Activated Platelets Despite the Presence of Activated Protein C

The Effect of Ellagic Acid on Coagulation in Vivo

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only